image
Aridis Pharmaceuticals, Inc. ARDS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.0001
0 %
$ 4.46 K
Market Cap
0.0
P/E
BALANCE SHEET
14.7 M ASSETS
-45.16%
Growth Rates
1Year -45.16%
3Years -19.31%
5Years -11.11%
7Years 0.00%
10Years 0.00%
38.9 M LIABILITIES
-4.84%
Growth Rates
1Year -4.84%
3Years 16.96%
5Years 20.95%
7Years 0.00%
10Years 0.00%
-24.2 M EQUITY
-71.74%
Growth Rates
1Year -71.74%
3Years -97.16%
5Years -25.55%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Aridis Pharmaceuticals, Inc.
image
Current Assets 11.6 M
Cash & Short-Term Investments 4.88 M
Receivables 1.24 M
Other Current Assets 5.51 M
Non-Current Assets 3.07 M
Long-Term Investments 0
PP&E 2.15 M
Other Non-Current Assets 922 K
Current Liabilities 36.9 M
Accounts Payable 2.31 M
Short-Term Debt 4.84 M
Other Current Liabilities 29.8 M
Non-Current Liabilities 2.03 M
Long-Term Debt 1.29 M
Other Non-Current Liabilities 737 K

Balance Sheet

Millions
Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 4.9 20.0 8.2 20.9 24.2 25.1 22.3
Short Term Investments 0 0 0 0 0 0 0
Receivables 1.2 0.2 0.4 0.4 2.1 0 67 K
Inventory 0 (0.2) (0.4) (0.4) (4.1) 0 0
Other Current Assets 5.5 6.1 4.2 4.5 2.0 0.2 51 K
Total Current Assets 11.6 26.8 15.1 28.0 24.2 25.3 22.4
PP&E 2.1 1.4 1.3 1.0 1.3 0.8 39 K
Intangible Assets 17 K 22 K 27 K 32 K 38 K 43 K 48 K
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 9 K 1.0 0 0
Other Long Term Assets 0.9 (1.4) (1.3) (1.0) 7.4 0.3 41 K
Other Assets 0 (2.3) (2.3) (1.6) 0 0 0
Total Assets 14.7 26.8 15.1 28.0 31.6 26.5 22.5
LIABILITIES
Accounts Payable 2.3 5.2 1.9 1.8 2.3 0.9 0.7
Short Term Debt 4.8 0.7 0.4 0 0 0 0
Other Current Liabilities 9.6 6.6 1.4 3.0 2.9 2.1 1.7
Total Current Liabilities 36.9 33.3 22.4 19.3 5.3 3.2 2.4
Long Term Debt 1.3 5.3 0.3 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0.4 0.2 0 0 11.9 6.4
Total Liabilities 38.9 40.9 23.8 24.3 5.3 15.0 8.8
EQUITY
Common Stock 3 K 2 K 1 K 1 K 1 K 0 0
Retained Earnings (195.7) (165.3) (123.1) (100.8) (71.1) (47.6) (20.2)
Other Accumulative Comprehensive Income/Loss 5.1 0 0 0 (0.5) (0.2) (0.2)
Total Equity (24.2) (14.1) (8.7) 3.6 26.3 11.4 13.8
Total Liabilities and Equity 14.7 26.8 15.1 28.0 31.6 26.5 22.5
SHARES OUTSTANDING
Common Shares Outstanding 18.8 12.3 9.2 8.5 3.1 7.9 7.9